1. Home
  2. YCBD vs QNRX Comparison

YCBD vs QNRX Comparison

Compare YCBD & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YCBD
  • QNRX
  • Stock Information
  • Founded
  • YCBD 2015
  • QNRX 2018
  • Country
  • YCBD United States
  • QNRX United States
  • Employees
  • YCBD N/A
  • QNRX N/A
  • Industry
  • YCBD Biotechnology: Pharmaceutical Preparations
  • QNRX Medical/Dental Instruments
  • Sector
  • YCBD Health Care
  • QNRX Health Care
  • Exchange
  • YCBD Nasdaq
  • QNRX Nasdaq
  • Market Cap
  • YCBD 1.9M
  • QNRX 2.1M
  • IPO Year
  • YCBD N/A
  • QNRX N/A
  • Fundamental
  • Price
  • YCBD $0.49
  • QNRX $0.62
  • Analyst Decision
  • YCBD
  • QNRX Strong Buy
  • Analyst Count
  • YCBD 0
  • QNRX 1
  • Target Price
  • YCBD N/A
  • QNRX $4.00
  • AVG Volume (30 Days)
  • YCBD 193.9K
  • QNRX 486.4K
  • Earning Date
  • YCBD 12-20-2024
  • QNRX 11-07-2024
  • Dividend Yield
  • YCBD N/A
  • QNRX N/A
  • EPS Growth
  • YCBD N/A
  • QNRX N/A
  • EPS
  • YCBD N/A
  • QNRX N/A
  • Revenue
  • YCBD $20,636,546.00
  • QNRX N/A
  • Revenue This Year
  • YCBD N/A
  • QNRX N/A
  • Revenue Next Year
  • YCBD $9.38
  • QNRX N/A
  • P/E Ratio
  • YCBD N/A
  • QNRX N/A
  • Revenue Growth
  • YCBD N/A
  • QNRX N/A
  • 52 Week Low
  • YCBD $0.42
  • QNRX $0.48
  • 52 Week High
  • YCBD $1.73
  • QNRX $6.18
  • Technical
  • Relative Strength Index (RSI)
  • YCBD 51.20
  • QNRX 43.57
  • Support Level
  • YCBD $0.42
  • QNRX $0.60
  • Resistance Level
  • YCBD $0.52
  • QNRX $0.77
  • Average True Range (ATR)
  • YCBD 0.05
  • QNRX 0.07
  • MACD
  • YCBD 0.00
  • QNRX -0.02
  • Stochastic Oscillator
  • YCBD 46.98
  • QNRX 12.98

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: